Overview
- Editors:
-
-
Gert J. Horst
-
Department of Biological Psychiatry, Groningen Center for Behavioral and Cognitive Neurosciences, University of Groningen, The Netherlands
-
Jakob Korf
-
Department of Biological Psychiatry, Groningen Center for Behavioral and Cognitive Neurosciences, University of Groningen, The Netherlands
Access this book
Other ways to access
Table of contents (11 chapters)
-
-
- Gert J. Ter Horst, Antonio Postigo
Pages 1-30
-
- Henk Stevens, Hugo M. L. Jansen, Jacques DeReuck, Jakob Korf
Pages 31-41
-
- Keith W. Muir, Elkan Gamzu, Kennedy R. Lees
Pages 43-66
-
- Paul G. M. Luiten, Bauke Stuiver, Gineke I. de Jong, Csaba Nyakas, Jacques H. A. De Keyser
Pages 67-99
-
-
- Midori A. Yenari, David C. Tong, Gregory W. Albers
Pages 127-151
-
-
- Christoph Wiessner, Konstantin-Alexander Hossmann
Pages 185-213
-
- Laura J. McIntosh, Robert M. Sapolsky
Pages 215-234
-
- John Sharkey, John S. Kelly, Steven P. Butcher
Pages 235-263
-
- Akira Tamura, Kensuke Kawai, Kiyoshi Takagi
Pages 265-294
-
Back Matter
Pages 295-305
About this book
A distinguished international panel of authors define our current understanding of neuronal damage after ischemia and critically review the significant recent developments and progress in cerebrovascular accident (CVA) drug trials, both in animal models and in the clinical setting. These leading basic and fundamental authorities survey such important new drugs as calcium-influx inhibitors, free-radical scavenging drugs, glutamate and glycinergic antagonists, and immune suppressors. They also evaluate all the latest findings concerning calcium homeostasis, glutamate toxicity, gene activation, and the role of free radicals, glycine, and hormones. Chapters devoted to the neuroimaging of stroke, clinical trials, and the role of cerebral immune activation complete this informative collection of cutting-edge reviews.
Reviews
". . .the new standard reference work for neurologists and neurosurgeons treating patients with CVA."-Trends in Neuroscience
